Leap Therapeutics Inc. buy Raymond James
Start price
14.11.23
/
50%
€1.37
Target price
14.11.24
€16.21
Performance (%)
63.50%
Price
23.05.24
€2.30
Summary
This prediction is currently active. With a performance of 63.50% the BUY prediction by Raymond_James is a big success. This prediction currently runs until 14.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Leap Therapeutics Inc. | -9.449% | -9.449% |
iShares Core DAX® | -0.654% | 1.989% |
iShares Nasdaq 100 | 0.903% | 5.664% |
iShares Nikkei 225® | -0.740% | -1.363% |
iShares S&P 500 | -0.013% | 3.020% |
Comments by Raymond_James for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat